Phase II Trials of Imatinib Mesylate and Docetaxel in Patients with Metastatic Non-small Cell Lung Cancer and Head and Neck Squamous Cell Carcinoma-Reference-Cited by-同舟云学术

Phase II Trials of Imatinib Mesylate and Docetaxel in Patients with Metastatic Non-small Cell Lung Cancer and Head and Neck Squamous Cell Carcinoma

Published:2011-12 Issue:12 Volume:6 Page:2104-2111
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Tsao Anne S.,Liu Suyu,Fujimoto Junya,Wistuba Ignacio I.,Lee J. Jack,Marom Edith M.,Charnsangavej Chusilp,Fossella Frank V.,Tran Hai T.,Blumenschein George R.,Papadimitrakopoulou Vassiliki,Kies Merrill S.,Hong Waun K.,Stewart David J.

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference47 articles.

1. PDGF receptors as cancer drug targets;Pietras;Cancer Cell,2003

2. Effects of blocking platelet-derived growth factor-receptor signaling in a mouse model of experimental prostate cancer bone metastases;Uehara;J Natl Cancer Inst,2003

3. Inhibition of platelet-derived growth factor receptors reduces interstitial hypertension and increases transcapillary transport in tumors;Pietras;Cancer Res,2001

4. Simultaneous blockade of platelet-derived growth factor-receptor and epidermal growth factor-receptor signaling and systemic administration of paclitaxel as therapy for human prostate cancer metastasis in bone of nude mice;Kim;Cancer Res,2004

5. Inhibition of PDGF receptor signaling in tumor stroma enhances antitumor effect of chemotherapy;Pietras;Cancer Res,2002

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dissecting the functions of cancer-associated fibroblasts to therapeutically target head and neck cancer microenvironment;Biomedicine & Pharmacotherapy;2023-05

2. Targeting Inflammation in Non-Small Cell Lung Cancer through Drug Repurposing;Pharmaceuticals;2023-03-16

3. Head and neck squamous cell carcinoma: Exploring frontiers of combinatorial approaches with tyrosine kinase inhibitors and immune checkpoint therapy;Critical Reviews in Oncology/Hematology;2022-12

4. Role of the ABL tyrosine kinases in the epithelial–mesenchymal transition and the metastatic cascade;Cell Communication and Signaling;2021-05-22

5. Clinical utility of a protein-based oncopanel in patients with end-stage head and neck cancer;Immunotherapy;2019-10